The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Balchem Corporation has announced a strategic investment aimed at enhancing its production capabilities for advanced microencapsulated technologies in the food ingredients market.

The new manufacturing facility, set to open in 2027 on a 12-acre site in Orange County, New York, will significantly expand the company’s capacity for its microencapsulation solutions, including BakeShure, ConfecShure and MeatShure.

This state-of-the-art facility is designed to address the growing demand for microencapsulated ingredients primarily used in bakery, confectionery and meat products.

These innovative solutions not only extend shelf life but also optimise texture and improve production efficiency, providing substantial benefits to both manufacturers and consumers.

Microencapsulation technology is critical for controlling the release and maintaining the functionality of sensitive food ingredients, which enhances stability and handling characteristics.

This capability is essential for manufacturers looking to improve product longevity and quality across various applications, from baked goods to meat products.

Ted Harris, chairman, president and CEO of Balchem, commented: “Our new facility will offer state-of-the-art equipment and processes, increased production capacity for our microencapsulation solutions, and a multitude of opportunities to advance the design, manufacture and application of controlled-release ingredients".

He added: "Building on over five decades of expertise, the new site will incorporate the latest advancements in food science and sustainable production, ensuring we meet the evolving needs of our customers.”

The decision to establish this new facility reflects Balchem’s commitment to innovation in the food ingredients sector and its strategic focus on strengthening its presence in the US market.

By enhancing production capabilities, Balchem aims to support ongoing innovation and improve service delivery for its global customer base.

This investment aligns with Balchem's broader mission to contribute positively to health and wellbeing through high-quality specialty ingredients.

The company’s Human Nutrition & Health segment is particularly focused on delivering customised ingredient systems for food, supplements and pharmaceuticals, while also addressing the needs of the animal nutrition market through its other business segments.